Managing biotech patents - what you need to know


If you know the biotech sector then you will know that biotech business leaders can generally be put into one of three groups. First are those who know what value their patents add to their business. Second are those who don't know what value their patents add. These may be those who know they don't know and include those who once knew but now know they no longer know. Or they may be those who don't know they don't know. And the third are those who don't know and don't care.

This article is intended for those in the second group who want to get into the first. It is also for those who might like to test the assumptions by which they placed themselves in the first group.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Intellectual Property Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Freehills Patent Attorneys | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »